Late-Breaking Clinical Trial Data Show Implant Success with Pacing Inside the Left Ventricle in Heart Failure Patients MINNEAPOLIS and SAN FRANCISCO - Medtronic, Inc. today released study findings ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure, today announced that the U.S. Food and Drug Administration (FDA) ...

A Baylor College of Medicine multi-institution, collaborative study to determine the effectiveness and safety of commonly used pacing treatments for cardiac resynchronization therapy in people with ...

All electrophysiologists had performed at least 20 successful implantations prior to the study. The primary endpoint was a ...

HonorHealth performed a groundbreaking procedure on a heart failure patient last month at its Scottsdale Shea Medical Center.

The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

The Integra-D trial shows the device, which provides cardiac contractility modulation and defibrillation, also eases symptoms ...

Cardiac resynchronization therapy (CRT), with or without a defibrillator, has been shown to improve symptoms, quality of life, and prognosis in patients with moderate-to-severe heart failure (HF) ...

New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "EU5 Cardiac Rhythm Management Procedures Outlook to 2025 - Pacemaker Implant Procedures, Cardiac ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cardiac Resynchronization Therapy (CRT) Market (2014-2025)" report to their offering. The global cardiac ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio SAN FRANCISCO — His bundle pacing as ...